Jacobs Stock Jumps 11.5% in a Month: Can This Rally Keep Running?

Jacobs’ Earnings Provide Fundamental Support

Fiscal third-quarter 2026 adjusted earnings rose 13.6% year over year to $1.84 per share, matching the Zacks Consensus Estimate. Gross revenues increased 34.5% to $4.08 billion and beat the consensus mark by 15.1%.

Adjusted net revenues, which exclude low-margin pass-through revenues, advanced 8.3% to $2.42 billion. The company raised its fiscal 2026 guidance for the third consecutive quarter, including adjusted earnings of $7.20-$7.30 per share.

J’s Record Backlog Extends Revenue Visibility

Backlog climbed 27.3% year over year to a record $28.9 billion. The quarterly gross revenue book-to-bill ratio was 1.5, while the trailing 12-month ratio remained 1.4.

Net revenues and gross profit embedded in backlog rose 11% and 14%, respectively. Management expects another active booking quarter and believes the backlog supports fiscal 2027 growth at least in line with its long-term average.

Jacobs’ AI Exposure Adds a Durable Demand Driver

Direct Artificial Intelligence build-out activity represented 11% of adjusted net revenues, up about 100 basis points sequentially. The exposure spans data centers, semiconductors, energy and power, water and digital services.

Life Sciences and Advanced Manufacturing adjusted net revenues increased 24.2%, the category’s strongest growth since Jacobs began reporting it. Fluor Corporation FLR is also pursuing Artificial Intelligence data-center work, while AECOM ACM continues to benefit from broad infrastructure demand and record backlog, underscoring the depth of spending across the engineering market.

J’s Margin and Cash Gains Strengthen the Story

Adjusted EBITDA increased 16.7% to $366.8 million, and the margin expanded 110 basis points to 15.2%. Revenue growth outpaced overhead, helping lift profitability despite transaction-related costs elsewhere in reported results.

Jacobs generated $541 million of adjusted free cash flow during the quarter. Net leverage declined to 1.8 from 2.1 in the prior quarter, while share repurchases reached $614 million through the first nine months of fiscal 2026.

Jacobs’ Valuation May Temper Further Upside

Jacobs trades at 17.9X forward 12-month earnings, above its five-year median of 16.9X. The multiple remains below 18.4X for its Zacks sub-industry, 20.7X for the Zacks Construction sector and 20.9X for the S&P 500.

That relative discount offers some support, but the stock is no longer priced below its own normal range. Public-sector funding shifts, large-project execution risk, currency volatility and PA Consulting integration costs could restrain additional gains.

J’s Momentum Signal Is Stronger Than Its Style Mix

The rally has fundamental backing, but its continuation likely depends on sustained bookings, margin progress and cash conversion. The current valuation makes consistent execution more important after the recent share-price advance.

Jacobs carries a Zacks Rank #2 (Buy), which points to a favorable near-term earnings-revision signal. Its Momentum Score of B fits the recent price strength, but the Value Score of C, Growth Score of D and VGM Score of D show that the stock is not equally attractive across investment styles. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Research Chief Names "Single Best Pick to Double"

From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.

This company targets millennial and Gen Z audiences, generating nearly $1 billion in revenue last quarter alone. A recent pullback makes now an ideal time to jump aboard. Of course, all our elite picks aren’t winners but this one could far surpass earlier Zacks’ Stocks Set to Double like Nano-X Imaging which shot up +129.6% in little more than 9 months.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research